| Prolonged treatment interruption in chronic HIV infection: a new strategy? | |
| | |
MedLine Citation:
|
PMID: 15668548 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The introduction of highly active antiretroviral therapy in 1995 dramatically decreased AIDS-related events and deaths rates; however, the enthusiasm among the medical and social community was soon limited by the growing incidence of various side-effects that often greatly limited patients' quality of life. The second problem caused by such a complex treatment consisted of sub-optimal adherence, with a consequent higher risk of the development of drug resistance. |
| | |
Authors:
|
Riccardo Giuntini; Canio Martinelli; Silvia Ambu; Dario Bartolozzi; Alberto Farese; Vieri Boddi; Francesco Leoncini |
Related Documents
:
|
2071388 - The issue of race and the client-therapist assignment. 2246318 - Discharge videotaping: a means of augmenting occupational and physical therapy. 7884228 - Cytomegalovirus encephalitis in two patients with aids receiving ganciclovir for cytome... 1011858 - The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema: a determina... 21247638 - A latent class analysis of dsm-iv criteria for pathological gambling: results from the ... 4025528 - Otitis media and the australian aboriginal. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: AIDS (London, England) Volume: 19 ISSN: 0269-9370 ISO Abbreviation: AIDS Publication Date: 2005 Jan |
Date Detail:
|
Created Date: 2005-01-25 Completed Date: 2005-09-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8710219 Medline TA: AIDS Country: England |
Other Details:
|
Languages: eng Pagination: 209-11 Citation Subset: IM; X |
Affiliation:
|
Infectious Diseases Unit, AOU Careggi, Florence, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antiretroviral Therapy, Highly Active / adverse effects, methods* CD4 Lymphocyte Count Chronic Disease Cohort Studies Didanosine / administration & dosage Drug Administration Schedule Female HIV Infections / drug therapy* HIV Protease Inhibitors / administration & dosage Humans Male Middle Aged RNA, Viral / analysis Reverse Transcriptase Inhibitors / administration & dosage Viral Load Zidovudine / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/HIV Protease Inhibitors; 0/RNA, Viral; 0/Reverse Transcriptase Inhibitors; 30516-87-1/Zidovudine; 69655-05-6/Didanosine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Identifying deaths from AIDS in South Africa.
Next Document: Short-course induction with boosted saquinavir monotherapy for naive patients with late-stage infect...